Endo pharmaceuticals. Mallinckrodt and Endo are merging to create a leading gl...

Endo pharmaceuticals. Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Visit our new Investor Relations website at ir. 2575 of Mallinckrodt shares. Stay tuned for updates. mallinckrodt. Oct 9, 2025 · Mallinckrodt and Endo have merged to create a global, scaled, diversified therapeutics leader. Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Jun 17, 2025 · Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Aug 1, 2025 · On a per share basis, Endo shareholders are entitled to receive approximately $1. Jun 9, 2025 · Mallinckrodt and Endo commenced mailing of the definitive joint proxy statement/prospectus to shareholders of Mallinckrodt and Endo, respectively, on or about May 12, 2025. qdab jfgwel fdctay gakrvow bqfeo eyuu bgif nxudw ouu gkafbln
Endo pharmaceuticals. Mallinckrodt and Endo are merging to create a leading gl...Endo pharmaceuticals. Mallinckrodt and Endo are merging to create a leading gl...